MARKET

OSMT

OSMT

Osmotica Pharmaceuticals Plc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.460
-1.280
-27.00%
Closed 16:00 10/22 EDT
OPEN
4.750
PREV CLOSE
4.740
HIGH
4.750
LOW
3.400
VOLUME
370.44K
TURNOVER
--
52 WEEK HIGH
9.75
52 WEEK LOW
2.200
MARKET CAP
177.00M
P/E (TTM)
-0.4887
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of OSMT and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

OSMT News

  • Osmotica Pharmaceuticals plc Appoints Industry Executive Michael J. DeBiasi to Board of Directors
  • GlobeNewswire.09/27 11:50
  • Vertical Pharmaceuticals LLC, an Osmotica company, Announces Presentation of Phase III RVL-1201 Clinical Trial Data in Patients with Acquired Blepharoptosis (droopy eyelid)
  • GlobeNewswire.09/18 11:50
  • Vertical Pharmaceuticals, LLC, an Osmotica Company, Announces Submission of New Drug Application for RVL-1201
  • GlobeNewswire.09/17 11:50
  • Osmotica files U.S. application for RVL-1201 for droopy eyelid
  • Seeking Alpha - Article.09/17 11:12

More

Industry

Biotechnology & Medical Research
+0.44%
Pharmaceuticals & Medical Research
+0.60%

Hot Stocks

Name
Price
%Change

About OSMT

Osmotica Pharmaceuticals plc is an integrated biopharmaceutical company. The Company is focused on the developing and commercialization of specialty products that target markets with underserved patient populations. The Company is focused on progressing Phase III candidates under clinical development Ontinua ER and RVL-1201. It has developed Ontinua ER using its proprietary Osmodex drug delivery system. Ontinua ER has been designated by the FDA as an Orphan Drug in this indication. The Company is conducting a second Phase III clinical trial of RVL-1201 for droopy eyelid. The Company’s promoted products include specialty neurology drugs, such as Lorzone and ConZip for pain management, as well as women's health products, such as Divigel for menopause and the OB Complete family of prescription prenatal dietary supplements. The Company’s non-promoted products portfolio include methylphenidate ER and VERT as well as smaller volume ANDAs and prescription dietary supplements.
More

Webull offers Osmotica Pharmaceuticals PLC (OSMT) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.